Search results
Viking’s new dual GLP-1R/GIPR agonist expected to start Phase III trials soon
Clinical Trials Arena· 5 days agoIn conclusion, Viking Therapeutics’ candidate may soon enter Phase III trials, with a head-to-head...
In conclusion, Viking Therapeutics’ candidate may soon enter Phase III trials, with a head-to-head...